Insulin glargine and lixisenatide Subcutaneous and Vanatab DX
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Vanatab DX and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: chlophedianol / guaifenesin / pseudoephedrine
Brand name: Vanatab DX
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Vanatol LQ
- Insulin glargine and lixisenatide Subcutaneous-Vanatol S
- Insulin glargine and lixisenatide Subcutaneous-Vanatrip
- Insulin glargine and lixisenatide Subcutaneous-Vancenase
- Insulin glargine and lixisenatide Subcutaneous-Vancenase AQ
- Insulin glargine and lixisenatide Subcutaneous-Vancenase AQ Double Strength
- Vanatab DX-Insulin glargine, recombinant Subcutaneous
- Vanatab DX-Insulin glulisine
- Vanatab DX-Insulin Glulisine (Cartridges and Pens)
- Vanatab DX-Insulin Glulisine (Vials)
- Vanatab DX-Insulin glulisine Subcutaneous
- Vanatab DX-Insulin human inhaled Inhalation